Target intelligence / Profile preview

POU class 5 homeobox 1 pseudogene 6 (POU5F1P6)

Target
POU5F1P6
Molecular classification
Pseudogene, Homeobox pseudogene, Processed pseudogene
01

Overview

POU class 5 homeobox 1 pseudogene 6 (POU5F1P6) is a member of the OCT4 (POU5F1) pseudogene family, formally classified as a pseudogene and not a functional protein-coding gene[3][4]. Pseudogenes are genomic sequences similar to known genes but are typically considered nonfunctional due to disabling mutations, truncations, or lack of regulatory elements[2][4]. Eight pseudogenes for OCT4 (POU5F1) have been identified in the human genome, of which POU5F1P6 is one[1]. Although some pseudogenes of OCT4, such as POU5F1P1, show evidence for transcription or potential protein-coding activity, there is currently no evidence indicating that POU5F1P6 produces a functional protein or directly participates in biological pathways[1][2][4]. Its biological role—if any—is presumed to be limited to RNA-mediated regulation of its parental gene or similar processes, but this remains unproven for POU5F1P6 specifically[1][2]. POU5F1P6 is not considered a therapeutic target, nor is it linked to drug interaction or established as a biomarker in clinical practice[4][5]. Key points: - POU5F1P6 is a processed pseudogene, not an active receptor, enzyme, transporter, or transcription factor[3][4]. - There is no evidence for therapeutic targeting, disease association, or clinical biomarker status for POU5F1P6[4][5]. - Some pseudogenes in this family (notably POU5F1P1) may have regulatory or protein-coding functions and possible relevance to cancer, but this does not extend to POU5F1P6 under current evidence[1][2].

Other names
POU5F1P6POU domain class 5, transcription factor 1 pseudogene 6
02

Biological functions

No established protein-coding function; possible non-coding RNA roles (regulation of parental gene expression)
03

Disease associations

Other (no direct disease role established for POU5F1P6; some OCT4/OCT4 pseudogenes have suggested involvement in cancer biology, but not specifically POU5F1P6)[1]

Beyond the preview

Go deeper on POU class 5 homeobox 1 pseudogene 6 (POU5F1P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POU class 5 homeobox 1 pseudogene 6 (POU5F1P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call